Teva Recalls Clozapine Tablets Due to Microbial Contamination
Teva Pharmaceuticals is recalling specific lots of Clozapine Tablets USP, 25 mg, due to microbial contamination of non-sterile products.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves microbial contamination, which poses a risk of harm, but no illnesses or injuries have been reported in the source text.
Plain-English summary
Teva Pharmaceuticals USA is recalling specific lots of Clozapine Tablets USP, 25 mg, due to microbial contamination of non-sterile products. The affected products include 100-count bottles (NDC 0093-4359-01), 500-count bottles (NDC 0093-4359-05), 100 Unit Dose Blisters per carton (NDC 0093-4359-93), and Individual Blister Packs (NDC 0093-4359-19). The recall is classified as Class II by the FDA.
The affected lots are Lot # 07C160 for the 100 and 500-count bottles, and Lot # 07C160A for the Unit Dose Blisters and Individual Blister Packs. All affected products have an expiration date of 03/18. The products were distributed nationwide.
Consumers and healthcare providers should stop using the affected lots and contact their pharmacist or Teva Pharmaceuticals for further instructions. This recall is precautionary, and no illnesses or injuries have been reported in the source text.
The recalled product
- Product
- Clozapine Tablets USP, 25 mg, 100-count bottle (NDC 0093-4359-01), 500- count bottle (NDC 0093-4359-05), 100 Unit Dose Blisters per carton (NDC 0093-4359-93), Individual Blister Pack (NDC 0093-4359-19), Rx Only, Manufactured By: Teva Pharmaceutical Industries Ltd., Jerusalem, 977
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Antipsychotic
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 100 (NDC 0093-4359-01) and 500 count bottles (NDC 0093-4359-05)- Lot # 07C160
- Exp. 03/18
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15